Posted on 12/26/17
Ocular Therapeutix Provides Legal Update
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 12/22/17
Proteostasis Therapeutics Completes Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (Nasdaq:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies . . .
Posted on 12/21/17
Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher's Cell Therapy Systems (CTS) activation reagents in . . .
Posted on 12/20/17
ImmuCell Prices $3 Million Public Offering of Common Shares
PORTLAND, Maine, Dec. 19, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that . . .
Posted on 12/20/17
Otsuka and X-Chem Enter into a Drug Discovery Research and License Collaboration
WALTHAM, Mass.--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and X-Chem, Inc. (X-Chem) announce that they have signed a collaborative research agreement to advance the discovery process for . . .
Posted on 12/20/17
ClearPath Development Company Launches Third Collaboration Under Strategic Partnership With Astellas Pharma
ClearPath Development Company (ClearPath) announced today it has initiated a third research collaboration with Astellas Pharma Inc. to combat infections. The new collaboration, executed by a . . .
Posted on 12/19/17
Is Cara Therapeutics, Inc. a Buy?
Small-cap biotech Cara Therapeutics (NASDAQ:CARA) is working to commercialize a drug to combat pain -- but the stock has managed to inflict a different sort of . . .
Posted on 12/19/17
Kala Pharmaceuticals: Will Santa Come Early?
Kala Pharmaceuticals, Inc. (KALA), is about to release some big news that will move this little company in a big way. This little company should have . . .
Posted on 12/18/17
Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Leber's Hereditary Optic Neuropathy
Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast . . .
Posted on 12/18/17
PatientPing Partners with Mercy Health
PatientPing, a health technology company connecting providers to seamlessly coordinate patient care, today announced a new partnership with Mercy Health, a Catholic healthcare ministry serving Ohio . . .
Posted on 12/18/17
PAREXEL Announces Enhanced Global Data Operations
BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation, a leading global biopharmaceutical services provider, today introduced its enhanced Global Data Operations (GDO) solution, with augmented processes and expertise that further . . .
Posted on 12/18/17
The 3 Best Biotech Stocks of 2017
Biotech stocks rocked in 2017. At least a lot of them did. The SPDR S&P Biotech ETF has chalked up a gain of 40% with only . . .
Posted on 12/17/17
Blueprint Medicines Closes Public Offering
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the closing of its . . .
Posted on 12/17/17
Verastem Prices Public Offering of Common Stock
BOSTON--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM), focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, today announced the pricing . . .
Posted on 12/17/17
PixarBio Announces Signed Agreement with Lubrizol’s Division
SALEM, N.H.--(BUSINESS WIRE)--PixarBio Corporation developers of NeuroRelease™NR14, a 14-day post-surgical pain treatment, announces an agreement between Particle Sciences (PSI), a Lubrizol Corporation Company, to cGMP manufacture . . .
Posted on 12/16/17
Mersana Therapeutics Added to NASDAQ Biotechnology Index
CAMBRIDGE, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug . . .
Posted on 12/16/17
Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index
WATERTOWN, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, . . .
Posted on 12/15/17
Jounce Therapeutics Added to NASDAQ Biotechnology Index
CAMBRIDGE, Mass., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 12/15/17
Acer Therapeutics Closes Underwritten Public Offering of Common Stock
NEWTON, Mass., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious . . .
Posted on 12/14/17
Verastem Announces Public Offering of Common Stock
BOSTON--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ:VSTM), focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, today announced that it intends . . .
Posted on 12/14/17
Amgen Teams Up With Cambridge Biotech Community
Amgen (NASDAQ:AMGN) and LabCentral today announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral. The two Golden Ticket winners were . . .
Posted on 12/14/17
Biostage Announces Binding Agreement For $4.0 Million Private Placement
Biostage, Inc. (OTCQB: BSTG),, a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, announced today . . .
Posted on 12/14/17
CVS Health Foundation Announces Grant to Increase Access to Provider Education and Diagnosis Program for Alzheimer's Disease
The CVS Health Foundation today announced a $550,000 commitment to the Alzheimer's Association, extending its support for a new program to enhance disease diagnosis and assessment . . .
Posted on 12/14/17
Dicerna Prices Follow-On Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, announced today the pricing of its underwritten registered public offering . . .
Posted on 12/14/17
Concert Pharmaceuticals to Be Added to NASDAQ Biotechnology Index
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI) effective prior to . . .
Boston
